Women prescribed the antiemetic agent metoclopramide during pregnancy appear to be at no significantly increased risk for adverse outcomes, including spontaneous abortion, stillbirth, and infants with ...

Metoclopramide use during early pregnancy was not associated with excess risk for congenital malformations. In the U.S., treatment of nausea and vomiting during early pregnancy usually involves ...

Metoclopramide, a central and peripheral dopamine type 2 receptor antagonist, has been used as an attractive and safer alternative to cisapride. To evaluate the effects of intravenous metoclopramide ...

Antiemetic, which is a specific blocker of dopamine D2 and serotonin receptors. It has antiemetic effect, eliminates nausea and hiccups. Reduces moving activity of the esophagus, increases the tone of ...

SOLANA BEACH, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders with an ...